Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanning Xu

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
ACS Nano|December 3, 2024
Recent Progress in Nanomedicine for the Diagnosis and Treatment of Alzheimer's DiseasesHan Yang, Haozhe Tan, Haifei Wen, et al.
Scientific Reports|June 24, 2020
Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor MicroenvironmentJuan Du, Yanning Xu, Saki Sasada, et al.
The Lancet. Diabetes & Endocrinology|September 11, 2023
The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysisYanning Xu, Arash Derakhshan, Ola Hysaj, et al.
The Lancet. Diabetes & Endocrinology|April 30, 2026
Natural history of thyroid function in ageing: an individual participant data analysis of 137 488 participants from 31 prospective cohort studiesYanning Xu, Ola Hysaj, Xiaoyi Qi, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
ACS Nano|December 3, 2024
Recent Progress in Nanomedicine for the Diagnosis and Treatment of Alzheimer's DiseasesHan Yang, Haozhe Tan, Haifei Wen, et al.
Scientific Reports|June 24, 2020
Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor MicroenvironmentJuan Du, Yanning Xu, Saki Sasada, et al.
The Lancet. Diabetes & Endocrinology|September 11, 2023
The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysisYanning Xu, Arash Derakhshan, Ola Hysaj, et al.
The Lancet. Diabetes & Endocrinology|April 30, 2026
Natural history of thyroid function in ageing: an individual participant data analysis of 137 488 participants from 31 prospective cohort studiesYanning Xu, Ola Hysaj, Xiaoyi Qi, et al.
Pageof 4